Cytodyn Inc (CYDY)

[BlackDoggie]

I agree that they’ll likely take safety data from the ongoing investigational trial for the upcoming pivotal, and that should lead to a smaller and quicker pivotal trial. I actually mentioned that recently. But we don’t even have a protocol for the pivotal yet. The quotes about avoiding long delays in the BLA filing are all directly related to filing for combo at 700mg instead of 350mg. I imagine all future trials will borrow safety data. Cancer, GvHD, etc. Likely all smaller due to the existing safety data and profile.

At least that’s how I read it. As I noted, I expect that in the long run you’ll be correct, but this one is all - and only - explicitly about the combo BLA borrowing safety data from investigational mono.